Ziltivekimab (COR-001) is a humanized monoclonal antibody designed to target interleukin-6 (IL-6), a cytokine known to play a critical role in systemic inflammation. This antibody has demonstrated efficacy in lowering serum C-reactive protein (CRP) levels, indicating its potent anti-inflammatory properties. Ziltivekimab is primarily utilized in research focused on chronic systemic inflammation, particularly in conditions such as chronic kidney disease (CKD) and cardiovascular diseases, including atherosclerosis. Its specific interaction with IL-6 makes it a valuable tool for studies exploring the pathophysiology and potential therapeutic interventions for these diseases.
Ziltivekimab (COR-001) is a humanized monoclonal antibody designed to target interleukin-6 (IL-6), a cytokine known to play a critical role in systemic inflammation. This antibody has demonstrated efficacy in lowering serum C-reactive protein (CRP) levels, indicating its potent anti-inflammatory properties. Ziltivekimab is primarily utilized in research focused on chronic systemic inflammation, particularly in conditions such as chronic kidney disease (CKD) and cardiovascular diseases, including atherosclerosis. Its specific interaction with IL-6 makes it a valuable tool for studies exploring the pathophysiology and potential therapeutic interventions for these diseases.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
